Stockscreener 앱 받기
54.94
1.84%
0.99
시간 외 거래:
54.95
0.01
+0.02%
전일 마감가:
$53.95
열려 있는:
$53.76
하루 거래량:
101.17K
Relative Volume:
0.32
시가총액:
$2.57B
수익:
-
순이익/손실:
-
주가수익비율:
-67.54
EPS:
-0.8135
순현금흐름:
-
1주 성능:
+10.63%
1개월 성능:
+26.85%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$50.59
$55.42
1주일 범위
$48.76
$55.42
52주 변동 폭
$23.00
$55.42
Hemab Therapeutics Holdings Inc Stock (COAG) Company Profile
명칭
Hemab Therapeutics Holdings Inc
전화
45 2138 7627
주소
101 MAIN STREET, CAMBRIDGE
Compare COAG vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COAG
Hemab Therapeutics Holdings Inc
|
54.94 | 2.50B | 0 | 0 | 0 | -0.8135 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Hemab Therapeutics Holdings Inc 주식(COAG)의 최신 뉴스
Novo Holdings A/S (COAG) discloses 9.0% beneficial stake in Hemab Therapeutics - Stock Titan
Avoro, Aghazadeh report 7.06% Hemab Therapeutics (COAG) ownership stake - Stock Titan
HC Wainwright Cuts Earnings Estimates for Hemab Therapeutics - marketbeat.com
Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64 - moomoo.com
Hemab Therapeutics (NASDAQ:COAG) Hits New 52-Week High After Analyst Upgrade - marketbeat.com
Hemab Therapeutics (COAG): Capital International Investors discloses 7.7% ownership - Stock Titan
Hemab Therapeutics stock price target raised to $60 by H.C. Wainwright - Investing.com Canada
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com
COAG SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
FMR LLC Acquires Stake in Hemab Therapeutics Holdings Inc (COAG) - GuruFocus
H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60 - Moomoo
Hemab Therapeutics Reports Q2 2026 Financials and Pipeline Progress in Latest 10-Q Filing - Kalkine Media
Hemab Therapeutics (COAG) widens loss but builds $457.5M cash war chest - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Price Target Raised to $60.00 at HC Wainwright - MarketBeat
Hemab Therapeutics Gains FDA Backing to Advance Sutacimig Into Phase 3 Trial for Glanzmann Thrombasthenia - Minichart
Form 8K Hemab Therapeutics Holdings For: 11 August By Investing.com - Investing.com Nigeria
Earnings Flash (COAG) Hemab Therapeutics Posts Q2 Net Loss $0.80 a Share, vs. FactSet Est of $0.56 Loss - marketscreener.com
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Hemab Therapeutics reports Q2 2026 net loss of $24.2M, cash runway into 2029 after $317M IPO proceeds - TradingView
Hemab Unveils Peptide-Based Approach to Heavy Menstrual Bleeding - Stock Titan
COAG Stock Price and Chart — NASDAQ:COAG - TradingView
Hemab Therapeutics (NASDAQ: COAG) investors detail 5.1% passive ownership stake - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Hits New 1-Year HighTime to Buy? - MarketBeat
FMR LLC reports 7.9% Hemab Therapeutics (COAG) stake on Schedule 13G - Stock Titan
Sofinnova group (NASDAQ: COAG) discloses 5.4% Hemab Therapeutics ownership on Schedule 13G - Stock Titan
Hemab Therapeutics (NASDAQ:COAG) Trading Down 4.8%What's Next? - marketbeat.com
Hemab Therapeutics Holdings Ord Shs (Proposed) - TradingKey
Hemab Therapeutics Holdings, Inc. Revenue Breakdown – NASDAQ:COAG - TradingView
Ra Capital Nexus Fund Iv, L.p. Net Worth (2026) - GuruFocus
Biotech stocks lead healthcare's overbought list as earnings picks up (XLV:NYSEARCA) - Seeking Alpha
Mads Nikolaj Behrndt Eriksen Net Worth (2026) - GuruFocus
Biotech IPO gains crush numerous AI listings - PressReader
Biotech IPO gains crush AI listings with standout 55% return - The Edge Singapore
Ananthram Sreenivasa Murthy Net Worth (2026) - GuruFocus
SpaceX Stock Closes At Fresh Low After Seven Straight Days Of Losses - Yahoo Finance
Ai Den Mab Llc Net Worth (2026) - GuruFocus
The Robot Maker's Paradox - Yahoo Finance
Hemab Therapeutics (NASDAQ:COAG) Hits New 12-Month HighWhat's Next? - MarketBeat
Culpeo Minerals expands Chile landholding by 45% with new licences - Yahoo Finance
After Plunging 32.2% in 4 Weeks, Here's Why the Trend Might Reverse for D-WAVE QUANTUM (QBTS) - Yahoo Finance
Insight Global Opens New Seattle Hub to Support Next Phase of Growth Across the Pacific Northwest - Yahoo Finance
DiamondRock Hospitality Company (DRH) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
IREN stock jumps as AI cloud contract wins lift annual revenue target - Yahoo Finance
Why this venture capitalist is bullish on Anthropic's IPO — not OpenAI's - Yahoo Finance
Plug Power vs. FuelCell: Both Are Hot in 2026, but Only One Is Worth Buying Now - Yahoo Finance
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability - Yahoo Finance
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why Is Lucid (LCID) Stock Rocketing Higher Today - Yahoo Finance
Sellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial Result - Yahoo Finance
Hemab Therapeutics (NASDAQ:COAG) Shares Up 5.5%Here's What Happened - MarketBeat
WESTSHORE TERMINALS ANNOUNCES AGREEMENT RENEWAL WITH EVR OPERATIONS LIMITED - Yahoo Finance
Hemab Therapeutics Holdings Inc (COAG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):